News March 5, 2025 - Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio Read More January 13, 2025 - Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System Read More December 30, 2024 - Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Read More November 1, 2024 - CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ renal denervation catheter Read More June 27, 2024 - CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) Read More April 24, 2024 - CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis Read More April 22, 2024 - ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Read More March 4, 2024 - Glycomine Announces Encouraging Efficacy Data from Ongoing Phase 2 Clinical Study in PMM2-CDG Read More January 22, 2024 - CalciMedica Announces Private Placement of up to Approximately $55 Million Read More August 9, 2023 - CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP) Read More